These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
449 related articles for article (PubMed ID: 16796558)
21. Informatics and modeling challenges in fragment-based drug discovery. Hubbard RE; Chen I; Davis B Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855 [TBL] [Abstract][Full Text] [Related]
22. Structural biology and drug discovery. Scapin G Curr Pharm Des; 2006; 12(17):2087-97. PubMed ID: 16796557 [TBL] [Abstract][Full Text] [Related]
23. Electrostatic-field and surface-shape similarity for virtual screening and pose prediction. Cleves AE; Johnson SR; Jain AN J Comput Aided Mol Des; 2019 Oct; 33(10):865-886. PubMed ID: 31650386 [TBL] [Abstract][Full Text] [Related]
24. Importance of molecular computer modeling in anticancer drug development. Geromichalos GD J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268 [TBL] [Abstract][Full Text] [Related]
25. Function and structure-based screening of compounds, peptides and proteins to identify drug candidates. Malik V; Dhanjal JK; Kumari A; Radhakrishnan N; Singh K; Sundar D Methods; 2017 Dec; 131():10-21. PubMed ID: 28843611 [TBL] [Abstract][Full Text] [Related]
27. Virtual compound screening in drug discovery. Stumpfe D; Ripphausen P; Bajorath J Future Med Chem; 2012 Apr; 4(5):593-602. PubMed ID: 22458679 [TBL] [Abstract][Full Text] [Related]
28. A spatial-temporal gated attention module for molecular property prediction based on molecular geometry. Li C; Wang J; Niu Z; Yao J; Zeng X Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822856 [TBL] [Abstract][Full Text] [Related]
29. Persistent spectral hypergraph based machine learning (PSH-ML) for protein-ligand binding affinity prediction. Liu X; Feng H; Wu J; Xia K Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33837771 [TBL] [Abstract][Full Text] [Related]
30. Computational approaches for ligand discovery and design in class-A G protein- coupled receptors. Rodríguez D; Gutiérrez-de-Terán H Curr Pharm Des; 2013; 19(12):2216-36. PubMed ID: 23016842 [TBL] [Abstract][Full Text] [Related]
31. Knowledge-driven lead discovery. Pirard B Mini Rev Med Chem; 2005 Nov; 5(11):1045-52. PubMed ID: 16307533 [TBL] [Abstract][Full Text] [Related]
32. Artificial intelligence in drug design. Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833 [TBL] [Abstract][Full Text] [Related]
33. Automatic clustering of docking poses in virtual screening process using self-organizing map. Bouvier G; Evrard-Todeschi N; Girault JP; Bertho G Bioinformatics; 2010 Jan; 26(1):53-60. PubMed ID: 19910307 [TBL] [Abstract][Full Text] [Related]
34. Virtual screening in drug discovery -- a computational perspective. Reddy AS; Pati SP; Kumar PP; Pradeep HN; Sastry GN Curr Protein Pept Sci; 2007 Aug; 8(4):329-51. PubMed ID: 17696867 [TBL] [Abstract][Full Text] [Related]
35. Molecular Dynamics as a Tool for Virtual Ligand Screening. Menchon G; Maveyraud L; Czaplicki G Methods Mol Biol; 2018; 1762():145-178. PubMed ID: 29594772 [TBL] [Abstract][Full Text] [Related]